Sotac Pharmaceuticals Limited — Shareholders meeting

Sotac Pharmaceuticals Limited has announced the date for its upcoming Annual General Meeting (AGM). The company has informed the stock exchanges that the meeting is scheduled to take place on September 30, 2026. This notice is a standard regulatory requirement for listed entities and serves as a formal announcement of the date when the company's board and shareholders will convene to discuss and approve key corporate matters.

For investors, this announcement is primarily a procedural update. It confirms the timing of the AGM, which is a crucial event where shareholders vote on resolutions, including the approval of financial statements and the election of directors. While the specific agenda items are not yet disclosed, the meeting date is a key milestone for the company's corporate calendar and provides a reference point for upcoming corporate actions.

Investors should watch for the company's official notice and agenda, which are typically released closer to the meeting date. This document will provide details on the resolutions to be voted upon. Monitoring the company's filings and any subsequent announcements following the meeting will be important for understanding the outcomes of the votes and any strategic decisions made by the board.